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SLX4 binds to three nucleases (XPF-ERCC1,MUS81-
EME1, andSLX1), and its deficiency leads to genomic
instability, sensitivity toDNAcrosslinking agents, and
Fanconi anemia. However, it is not understood how
SLX4 and its associated nucleases act in DNA cross-
link repair. Here,weuncover consequences ofmouse
Slx4 deficiency and reveal its function in DNA cross-
link repair.Slx4-deficientmicedevelop epithelial can-
cers and have a contracted hematopoietic stem cell
pool. The N-terminal domain of SLX4 (mini-SLX4)
that only binds to XPF-ERCC1 is sufficient to confer
resistance to DNA crosslinking agents. Recombinant
mini-SLX4 enhances XPF-ERCC1 nuclease activity
up to100-fold, directing specificity towardDNA forks.
Mini-SLX4-XPF-ERCC1 also vigorously stimulates
dual incisions around a DNA crosslink embedded
in a synthetic replication fork, an essential step in
the repair of this lesion. These observations define
vertebrate SLX4 as a tumor suppressor, which acti-
vates XPF-ERCC1 nuclease specificity in DNA cross-
link repair.
INTRODUCTION
Organisms have evolved mechanisms to preserve genome
integrity, without which their DNA is prone to the accumulation
of damage and mutation (Lindahl, 1993). DNA damage occurs
from exposure to exogenous mutagens and endogenous reac-
tive processes, including DNA replication (Barnes and Lindahl,
2004). Because there aremany sources of damage, the chemical
nature of modified DNA can be very diverse, necessitating spe-
cific mechanisms of DNA damage recognition and repair. Inter-
strand crosslinks (ICLs) are a particularly deleterious form of
DNA damage. If they are not removed, ICLs block DNA replica-
tion, whereas their incomplete repair can also lead to the472 Molecular Cell 54, 472–484, May 8, 2014 ª2014 The Authorsaccumulation of double-strand breaks (DSBs) (Auerbach and
Wolman, 1976). Although we do not know how such lesions
naturally arise, they are readily formed when cells are exposed
to chemotherapeutic agents, such as cisplatin. As an ICL cova-
lently joins opposite strands of DNA together, its resolution is a
complex process requiring multiple steps.
The best insight into the mechanism of ICL repair has been
gained from elegant studies using Xenopus egg extracts
in vitro (Knipscheer et al., 2009; Long et al., 2011; Ra¨schle
et al., 2008). This system enabled the replication-coupled repair
of a single site-specific ICL to be followed at nucleotide resolu-
tion. In this system, two replication forks converge upon the
crosslink, pausing 20 nucleotides (nt) away from the lesion. Sub-
sequently, one fork progresses, and when it reaches the lesion,
dual incision at either side of the ICL occurs. These cleavage
events occur on the opposite, lagging strand template from
advancing replication (Ra¨schle et al., 2008). This critical step is
known as ‘‘unhooking’’ and allows sister chromatid separation.
The lesion is then bypassed using a trans-lesion synthesis
(TLS) polymerase, with subsequent extension being facilitated
by the Rev1-Rev7-Rev3 complex (Knipscheer et al., 2009;
Niedzwiedz et al., 2004; Ra¨schle et al., 2008; Simpson and
Sale, 2003). This results in the regeneration of an intact sister
chromatid that can serve as a template for homologous recom-
bination (HR) to repair the residual DSB (Long et al., 2011). The
identity of the proteins responsible for this complex repair pro-
cess have largely been identified by genetic means in several
organisms and can be classified into four major groups: (1) the
Fanconi anemia proteins (the genes encoding these are mutated
in the human chromosome breakage illness Fanconi anemia
[FA]), (2) structure-specific endonucleases required to unhook
the crosslink, (3) DNA polymerases that bypass lesions, and (4)
DNA double-strand break repair proteins that function in HR.
Three of these groups have obvious roles in DNA repair, but
until recently the exact function of the Fanconi proteins in ICL
repair remained elusive. The primary function of the upstream
components of the Fanconi DNA repair pathway is to monoubi-
quitylate two proteins: FANCD2 and FANCI (Garcia-Higuera
et al., 2001; Smogorzewska et al., 2007). Upon monoubiquityla-
tion, these two key repair factors are recruited to chromatin.
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the site of the lesion: its depletion results in a failure to unhook
a crosslink (Knipscheer et al., 2009). Despite this major advance
in understanding, the identity of the nuclease(s) that unhook
crosslinked DNA remains unclear—deficiency in any one of
six nucleases (XPF-ERCC1, MUS81-EME1, SLX1, SNM1A,
SNM1B, or FAN1) leads to cellular hypersensitivity to DNA cross-
linking agents (Castor et al., 2013; Demuth et al., 2004; Kratz
et al., 2010; Liu et al., 2010; MacKay et al., 2010; Sengerova´
et al., 2012; Smogorzewska et al., 2010; Wang et al., 2011;
Wyatt et al., 2013).
Although all six nucleases are required to protect cells from the
toxic effects of crosslinking agents, it is unlikely that they all act in
the same pathway as FA proteins. SNM1A and SNM1B are
members of a conserved exonuclease family, so their involve-
ment in ICL repair probably follows the primary incisions at a
crosslink (Wang et al., 2011). FAN1 can physically interact with
FANCD2, though the physiological relevance of this interaction
is unclear, because humans with FAN1 deficiency do not
develop FA (MacKay et al., 2010; Trujillo et al., 2012; Zhou
et al., 2012). Additionally, genetic analysis has revealed that
FAN1 does not act in a common pathway with the Fanconi genes
to repair an ICL (Yoshikiyo et al., 2010). MUS81-EME1-deficient
cells are hypersensitive to crosslinking agents, but MUS81-
EME1 knockout mice are fertile, in stark contrast to all FA
knockout mice (Dendouga et al., 2005; McPherson et al.,
2004). An Slx1-deficient mouse also shares similarities to
Mus81-deficiency, again suggesting a nonoverlapping func-
tion with the FA genes (Castor et al., 2013). However, as no hu-
man patients lacking MUS81-EME1 or SLX1 have yet been
described, it is still possible that these nucleases might consti-
tute extremely rare FA complementation groups.
In contrast, mutations in the nuclease XPF-ERCC1 can lead to
FA, albeit with more severe clinical features than most common
complementation groups (Bogliolo et al., 2013; Kashiyama et al.,
2013). Furthermore, Ercc1-deficient mice also recapitulate many
aspects of FA, such as bone marrow dysfunction, sterility, and
developmental defects (Hsia et al., 2003; McWhir et al., 1993;
Prasher et al., 2005). However, this key nuclease has additional
roles in other repair processes, including gene conversion, single
strand annealing, and nucleotide excision repair (NER) (Al-Min-
awi et al., 2008; Niedernhofer et al., 2001; Sijbers et al., 1996).
Despite this, it has been shown that XPF-ERCC1 is required for
efficient crosslink unhooking in vivo (Bhagwat et al., 2009; De
Silva et al., 2000). In addition, in-vitro-purified XPF-ERCC1 is
able to unhook a crosslink, though it does so with poor efficiency
(Fisher et al., 2008; Kuraoka et al., 2000).
Taken together, the genetic and biochemical evidence impli-
cate XPF-ERCC1 as the most likely nuclease to unhook a DNA
crosslink in the context of the FA pathway. But does XPF-
ERCC1 achieve this on its own? Intriguingly, XPF-ERCC1,
MUS81-EME1, and SLX1 all interact with a large protein—
SLX4—that is thought to act as a scaffold (Andersen et al.,
2009; Fekairi et al., 2009; Mun˜oz et al., 2009; Svendsen et al.,
2009). Surprisingly, SLX4 deficiency in humans leads to classical
Fanconi anemia, and Slx4-deficient mice phenocopy many as-
pects of this human illness (Crossan et al., 2011; Kim et al.,
2011; Stoepker et al., 2011). Cells lackingSlx4 are hypersensitiveto DNA crosslinking agents, and this defect can only be comple-
mented by SLX4 polypeptides that retain the interaction with
XPF-ERCC1 (Crossan et al., 2011; Kim et al., 2013). Furthermore,
sequential deletion and mutation analysis revealed that defects
in the interaction with MUS81-EME1 and SLX1 are marginally
responsible for the function of SLX4 in DNA crosslink repair
(Castor et al., 2013; Kim et al., 2013). Thus, an SLX4-XPF-
ERCC1 complex could be the key incision nuclease that un-
hooks DNA crosslinks in vertebrates.
In this study, we assess the long-term consequences of Slx4
deficiency in mice. We define a minimal SLX4 polypeptide that
only interacts with XPF-ERCC1 nuclease that can support cross-
link repair. Biochemical analysis of this mini-SLX4-XPF-ERCC1
complex reveals that SLX4 vigorously stimulates XPF-ERCC1
nuclease to cut replication intermediates and unhook an ICL.
RESULTS
Mouse Slx4 Deficiency Leads to Epithelial Cancer
Predisposition and Reduced Blood Stem Cells
We previously characterized homozygous mice carrying the
Btbd12tm1a(EUCOMM)Wtsi allele (hereafter referred to as Slx4f3).
These mice have been maintained for many generations in a
pure C57BL/6NTac background. Homozygous Slx4f3/f3 mice
were born at sub-Mendelian ratios, were sterile, prone to devel-
opmental defects, and hematological cytopenias—these fea-
tures persist in our colony following transmission of the allele
through several generations. Transformed murine embryonic
fibroblasts (MEFs) made from these mice were hypersensitive
to DNA crosslinks and accumulated broken chromosomes
(Crossan et al., 2011). These features bear striking resemblance
to FA. We have now followed a cohort of Slx4f3/f3 homozygous
mice for up to 2 years: most of these animals succumbed to
malignancies within this time frame. The pattern of tumors was
atypical, with epithelial-type cancers predominating (rectal
squamous cell carcinoma and hepatocellular carcinoma) (Fig-
ures 1A–1C). Though some human FA patients develop a range
of cancers, most of them have hematopoietic stem cell defects,
leading to bone marrow failure (Ceccaldi et al., 2012; Garaycoe-
chea and Patel, 2014). Our previous work showed that the blood
from a small proportion of homozygous Slx4f3/f3 mice displayed
reduced white blood cell and platelet numbers, prompting us to
determine the frequency of hematopoietic stem and progenitor
cells (HSPC) residing in the bone marrow of 8- to 12-week old
mice. Flow cytometry analysis of the bone marrow for the Line-
agec-kit+Sca1+ (LKS) population shows that this is contracted
in Slx4f3/f3 compared to controls (Figure 1D). Furthermore, we
carried out a spleen colony forming assay in lethally irradiated
recipients, using wild-type or Slx4f3/f3 bone marrow (CFU-S10).
These data confirm the reduction in the frequency of HSPCs
observed by flow cytometry (Figure 1E). In summary, mouse
Slx4 is a tumor suppressor that also functions to preserve
hematopoiesis.
Genetic Analysis and Purification of a Minimal
SLX4-XPF-ERCC1 Protein Complex
As already mentioned, transformed MEF cells lines obtained
from Slx4f3/f3 embryos were hypersensitive to ICL agents, suchMolecular Cell 54, 472–484, May 8, 2014 ª2014 The Authors 473
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Figure 1. Slx4-Deficient Mice Are Cancer Prone and Have a Compromised HSPC Pool
(A) Kaplan-Meier curve showing the tumor-free survival of our cohort of aged Slx4f3/f3 C57BL/6NTac mice (n = 28) and congenic controls (n = 28).
(B) Hematoxylin and eosin staining of sections of liver in (1) 8-week-old and (2) 24-week-old Slx4f3/f3 mice, revealing karyomegaly and steatosis. (3) Gross
pathology of a typical hepatic mass in Slx4f3/f3. (4) Histology of Slx4f3/f3 hepatic mass, showing a primary hepatocellular cancer.
(C) (1) Low-power magnification of an anal mass (black arrow), and (2) higher magnification shows features of a typical squamous cell carcinoma with keratin
whorls of the rectum.
(D) Flow cytometry analysis of total bone marrow from Slx4+/+ and Slx4f3/f3 mice stained with hematopoietic stem and progenitor cell markers (Linagec-kit+
Sca1+: LKS box).
(E) Spleen colony forming assay (CFU-S10) was performed in lethally irradiated recipients revealing a reduction in the Slx4
f3/f3 bone marrow. Error bars represent
SEM. ****p < 0.0001.
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transgene into these cells can complement this key phenotypic
feature. This simple, cell-intrinsic DNA repair defect provides a
system for functional dissection of the SLX4 polypeptide. SLX4
is a large 1565 amino acid polypeptide that serves as a binding
platform for three nucleases (Figure 2A). An N-terminal MLR
domain mediates the interaction with XPF-ERCC1, whereas474 Molecular Cell 54, 472–484, May 8, 2014 ª2014 The AuthorsMUS81-EME1 and SLX1 bind through regions mapping near
the C terminus of SLX4 (Fekairi et al., 2009; Kim et al., 2013;
Svendsen et al., 2009). Additionally, SLX4 possess two N-termi-
nal UBZ domains and a central BTB/POZ protein dimerization/
interaction domain. We created a truncation of mouse SLX4
(SLX4 1-758: mini-SLX4) that includes the XPF-ERCC1 binding
region (MLR) and ectopically expressed this in Slx4f3/f3-deficient
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efficiently as the full-length SLX4 polypeptide (Figure 2B). This
mini-SLX4 also significantly complements resistance to
MMC (Figure 2C) (LD50 values: Slx4
f3/f3 4 ng/ml, Mini-SLX4
23 ng/ml, and full-length SLX4 80 ng/ml).
We next studied the biochemical properties of mini-SLX4, to
ask if it modulates the function of XPF-ERCC1. Using insect cells
we expressed and purified the mini-SLX4-XPF-ERCC1 (SXE)
complex, the XPF-ERCC1 nuclease (XE), or mini-SLX4 alone
(Figure 2D; Figure S1 available online). To compare the proper-
ties of these proteins, we performed analytical gel filtration and
found that mini-SLX4 was polydispersed, forming high-molecu-
lar-mass aggregates (Figure 2E). In contrast, SXE formed a sta-
ble, monodispersed complex, indicated by a single peak on gel
filtration (Figure 2E). We confirmed these observations using
light-scattering analysis (Figure S1F). The molecular mass of
the SXE complex was 430 kDa, consistent with the formation
of homodimeric SXE complex. These results show that mini-
SLX4, which only interacts with XPF-ERCC1, was proficient in
ICL repair and that recombinant mini-SLX4-XPF-ERCC1 can
be readily purified.
Mini-SLX4 Alters the Nuclease Activity of XPF-ERCC1
on DNA Structures
Having established a robust purification strategy for the SXE
complex, we set out to compare its nuclease activity with that
of XE alone. A critical control was to purify both complexes car-
rying an XPF point mutation (D688A), known to ablate nuclease
activity (Figure 3A; SXE DA and XE DA). The equivalent mutation
in human XPF disrupts metal binding at the active site (Figures
S2A and S2B) (Enzlin and Scha¨rer, 2002).
A range of DNA oligonucleotides of varying complexity were
designed to test the effect of SLX4 on XPF-ERCC1 nuclease ac-
tivity. These ranged from simple single-stranded DNA (ssDNA) to
more complex replication fork and stem-loop substrates (Fig-
ure S3A). On ssDNA we observed no activity with the wild-type
(WT) complexes, consistent with the structure-specific nature
of XPF-ERCC1. SXE showed a weak activity in nicking double-
stranded DNA that was not observed for XE alone. Similarly,
a 50 overhang was cut weakly at its duplex end by SXE. This
weak activity was always observed in substrates containing a
free duplex. SXE showed marked activity when it was presented
with a 30 overhang (Figure 3B). The significant difference came
when we tested a short stem-loop structure and Y-shaped sub-
strates, mimicking stalled replication fork (Figure 3C). This stem-
loop substrate has frequently been used as a surrogate for NER
substrates (Bowles et al., 2012; Enzlin and Scha¨rer, 2002). Both
SXE and XE cleaved this short stem-loop structure with similar
efficiency (except for the aforementioned weak SXE activity
on the duplex end). Surprisingly, we observed a suppression
of XE activity on this stem-loop, when we titrated in free
mini-SLX4, suggesting the complex requires preassembly for
in vitro activity (data not shown). These data are similar to those
described in the accompanying study by Klein Douwel et al.
(2014), in which full-length Xenopus SLX4 exerted a slight inhib-
itory effect on XPF-ERCC1 activity. In contrast, SXE showed
enhanced activity at Y fork (30 Cy5 Y) structured DNA compared
to XE, which produced very little product. Furthermore, thisenhancement of structure-specific activity was restricted to the
30 arm (30 Cy5 Y) and could not be detected on the 50 arm (50
HEX Y) (Figure 3C). The cleavage site was close to the single-
strand/double-strand junction (two nucleotides into the duplex),
the canonical site for XE cleavage (de Laat et al., 1998). Impor-
tantly, the XE or SXE protein complexes, harboring XPF D688A
(or D690S, which is described later; data not shown) had no
discernable enzyme activity toward any DNA substrate tested.
Finally, we wanted to know if the enhanced activity of SXE on
Y-shaped structures was due to enhanced substrate binding.
We therefore compared the binding of XE and SXE to both Y
and short stem-loop substrates, using fluorescence anisotropy
in the absence of metal ions (Figure 3D). Binding to the stem-
loop DNA was equivalent for both complexes (KD 124 ± 8 nM
and 118 ± 5 nM for XE and SXE, respectively) (Su et al., 2012).
When we assayed the Y substrate, surprisingly we found SXE
binding was approximately 2-fold lower than XE (KD 143 ±
5 nM and 366 ± 22 nM for XE and SXE, respectively). Cumula-
tively, the above data suggest that purified SXE is a more potent
nuclease than XE; yet, the effect of mini-SLX4 on XPF-ERCC1
activity is more pronounced on specific substrates. Furthermore,
this difference is not entirely due to a change in DNA binding,
suggesting that SLX4 directly alters the catalytic properties of
XPF-ERCC1.
The SXE Nuclease Complex Is Most Active on
Fork-Structured DNA
Our qualitative analysis had revealed an effect of mini-SLX4 on
XPF-ERCC1 activity toward specific DNA structures. We next
sought to test this definitively, assessing the reaction kinetics
with an excess of enzyme and divalent metal (Mg2+) over sub-
strate. We designed three substrates of identical length and
sequence at the ss/ds junction (Figures 4 and S3B). The first
two substrates (long stem loop and bubble) were similar to those
used to characterize nuclease biochemistry in NER pathways
(Enzlin and Scha¨rer, 2002; Evans et al., 1997). Comparison of
XE and SXE activities toward this stem loop revealed a modest
rate enhancement of SXE (3.7-fold) (Figure 4A). These data differ
from those for the short stem-loop substrate previously
described, in which we observed marginally less activity of the
SXE complex (Figures 3C and S4). The length of the duplex
(and a possible contribution of DNA sequence; Bowles et al.,
2012) could explain this difference. Next, we assessed the
activity of the nuclease complexes toward bubble NER-like sub-
strates (Figure 4B). There was a striking concordance for rates of
catalysis of the bubble substrate with data for the stem loop. SXE
displayed a similarly modest 3.5-fold induction in catalytic rate
compared to XE. However, when we assayed fork-structured
DNA, we observed a greater difference between the enzyme
complexes (Figure 4C). XE processed the fork substrate (Y11)
with similar efficiency to the loop and bubble substrates (half-
life 16 min), indicating that in the absence of SLX4 it exhibited
very little structural preference (on these substrates). In compar-
ison, the Y11 fork was processed rapidly by SXE (half-life 1 min)
compared to XE, a 16-fold increase in catalytic activity. Reaction
rates are listed in Table S1. Thus, the structural DNAmotif recog-
nized by XE and SXE differs substantially; SLX4 effectively
biases XPF-ERCC1 toward processing forked DNA structures.Molecular Cell 54, 472–484, May 8, 2014 ª2014 The Authors 475
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Figure 2. SLX4 1-758 Partially Complements Crosslinker Sensitivity and Can Be Purified in a Complex with XPF-ERCC1
(A) Cartoon depicts the SLX4 polypeptide (1–1565), domains, and interactionswith the three nucleases: XPF-ERCC1,MUS81-EME1, and SLX1. A truncated SLX4
1-758 (mini-SLX4) contains the region that interacts with XPF-ERCC1.
(B) Full-length FLAG-tagged SLX4 or FLAG-tagged mini-SLX4 was expressed in Slx4f3/f3 MEFs. Anti-FLAG immunoprecipitation shows that the ectopically
expressed SLX4 polypeptides can be copurified with XPF-ERCC1. Note: ectopically expressed full-length SLX4 is prone to degradation/aggregation, accounting
for the three bands seen by western blot (WB).
(legend continued on next page)
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Figure 3. Comparison of the Activities of XE and SXE and Nuclease-Dead Mutants on Various Synthetic DNA Substrates
(A) Coomassie gel (top) and western blot (WB) analysis (bottom) of the purified SXE, XE complexes with WT XPF, or catalytically dead mutant D688A (DA) used in
the following assays and XPF Fanconi mutation R690S (RS). ERCC1 forms a doublet on WB, owing to a proteolytic site in the N terminus, shifting its mass by
2 kDa (*).
(B) Activity ofWTSXE/XE or DASXE/XE onDNA structures; single-stranded (ssDNA), double-stranded (dsDNA), 30 overhang (30 OH), and 50 overhang (50 OH). SXE
shows enhanced activity toward 30 overhangs (red arrow) and also low double-strand nicking activity (black arrow). The colored symbols denote fluorophore-
labeled nucleotides. Red arrow marks structure-specific activity.
(C) Activity of WT SXE/XE or DA SXE/XE on more complex splayed arms (50 HEX Y, 30 Cy5 Y) and stem-loop structures. SXE shows an induction in cleaving the 30
end of Y-shaped substrate, cleaving near the ss/ds junction (21 nt marker).
(D) Fluorescence anisotropy assay to determine binding of SXE and XE to either short stem-loop or splayed arms. Mini-SLX4 does not enhance the binding of XE
to either short stem-loop or splayed arms. Normalized and averaged anisotropy ± SEM.
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Structured DNA
The enhanced activity of SXE on fork-structured DNA prompted
us to extend our analysis to see if mini-SLX4 augmented XPF-(C) MTS viability of Slx4f3/f3 MEFs stably expressing full-length FLAG-SLX4 or FL
(D) Expression and purification of a recombinant mini-SLX4 (1–758) in complex wit
a Coomassie gel depicting the various stages of purification.
(E) Analytical gel filtration andCoomassie gels of purifiedmini-SLX4, XPF-ERCC1
the Commassie gel. The shaded box represents those fractions loaded on SDS g
represent SEM.ERCC1 activity at an ICL. We made a fork-structured DNA sub-
strate that contained a single site-specific nitrogen mustard-like
crosslink close to the ss/ds junction (Figures 5A and S3C) (Ange-
lov et al., 2009; Guainazzi et al., 2010). This simplified substrateAG-mini-SLX4, exposed to varying doses of Mitomycin C (MMC) for 4 days.
h XPF-ERCC1 (SXE) from insect cells. The purification scheme is shown next to
(XE), and SXE complexes. Italicized letters correspond to the proteins shown on
els (below). A red arrow denotes the column void volume (2 MDa). Error bars
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Figure 4. Mini-SLX4 Specifically Enhances XPF-ERCC1 Activity toward Y-Structured DNA
(A–C) XE and SXE (5 nM) were reacted with different radiolabeled DNA substrates (1.5 pM), over a time course (A, long stem-loop; B, bubble; C, fork-structured
DNA [Y11]). Substrates had identical primary sequence around the ss/ds bifurcation (depicted in red). The reaction products were separated by 12% denaturing
PAGE gel (top panel), and the decay of the substrate band (S) was quantified and expressed as a percentage of initial substrate (middle panel). Data were fitted
using single exponential decay in order to calculate reaction rates (bottom panel). XE data are plotted in blue; SXE data are plotted in red. SXE shows a modest
stimulation of activity compared to XE toward stem-loop and bubble substrates and a pronounced induction of activity toward forked DNA (Y11). Error bars
represent SEM.
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this substrate should result in labels on both strands of the fork,
allowing us to trace multiple products simultaneously. Based on
the cleavage products we observed for a noncrosslinked fork,
it was possible to predict the mass of products from the
ICL incision, thereby assessing whether the lesion was cut at
either side (unhooked). A cut site 30 of the crosslink (green
arrow) should result in labeled product much greater than
(>>) 35 nt in mass. If this product was in turn cut 50 to the
lesion (red arrow), two radiolabeled products should be gener-
ated: >35 (the unhooked strand) and%15 nt (the strand adjacent
to the ICL).
To test this prediction, we labeled the 50 termini of the sub-
strate and compared the reaction products of an ICL with a non-
ICL fork (YF), labeled on the leading strand template (Figure 5B).478 Molecular Cell 54, 472–484, May 8, 2014 ª2014 The AuthorsThe experiment revealed that an initial product formed,migrating
>>35 nt (the size of a single noncrosslinked substrate arm of the
YF substrate is 35 nt), indeed suggesting this must be a partially
incised, crosslinked product (Figure 5B, green arrow). To verify
this, we instead radiolabeled the 30 termini of ICL and compared
its digestion with 30-labeled YF (Figure S5). This reaction pro-
duced a complementary picture, confirming that initial cleavage
occurred 1 nt within the duplex (green arrowheads; Figures S5B
and S5C). We noticed that as the reaction with the 50-labeled ICL
substrate proceeded, the initial >>35 nt product diminished,
with the concomitant accumulation of a smaller >35 product
(Figure 5B, red bracket) and 15 nt product for both ICL and
YF substrates (Figure 5B, red arrowhead). We therefore
wanted to confirm if these products were linked to crosslink
‘‘unhooking.’’
AB C
Figure 5. SLX4 Promotes Unhooking of an ICL by XPF-ERCC1
(A) Outline of forked substrate containing a single nitrogen mustard-like interstrand crosslink (ICL) and its predicted reaction products. The substrate was
generated from two oligonucleotides (each 35 nucleotides in length) with a crosslink between adjacent guanines, close to the ss/ds junction (red boxed inset).
Sequential unhooking of the crosslinked DNA should result in an intermediate product (>>35 nt), followed by final products >35 and%15 nt (illustrated with green
and red arrowheads).
(B) The forked ICL substrate or an identical, but noncrosslinked, control (YF) were radiolabeled at the 50 end and reacted with XE or SXE enzyme complexes and
analyzed by denaturing PAGE. Cleavage sites and reaction products corresponding to those illustrated in (A) are shown as arrows and brackets (the equivalent
products fromYFmigrate at 19 and 15 nt). Comparison of ICL and YF digestion reveals the first >>35 nt product is most likely to result from an incision at the ss/ds
boundary (corresponding to 19 nt product of noncrosslinked YF fork). This was confirmed with 30-end labeling (Figure S5).
(C) The primary reaction product (>>35 nt, green box) from the ICL substrate was purified as a substrate in a second reaction (‘‘incised ICL’’) to test whether the
ICL was cleaved again (unhooked). The 15 and >35 nt product (red arrowhead and brackets) correspond to cleavage 50 of the adducted guanine. All reactions
contained 5 nM enzyme complex and 1.5 pM substrate. An asterisk denotes a low abundance, background band (a contaminant noncrosslinked oligonu-
cleotide). Representative gels depict experiments performed at least three times.
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excess of XE (25 nM, 60 min) to prepare an incised ICL interme-
diate (Figure 5C, green box, >>35 nt; explained in detail in Fig-
ures S6A and S6B). We used XE alone for this preparatory
experiment because the reaction proceeded too rapidly with
SXE, making it difficult to isolate the intermediate product. The
product was PAGE-purified to serve as a substrate (‘‘incised
ICL’’) in a second reaction, comparing the two enzyme com-
plexes. Significantly, we found that on this incised ICL substrate,
SXE complex rapidly catalyzed a second incision step, yieldingthe same two final products (>35 nt [red bracket] and 15 nt [red
arrowhead]) as the full ICL substrate (Figure 5C). This indicates
that SXE catalysis at the second site is not dependent on the
presence of the 30 arm. Furthermore, these bands (15 and >35
nt) form at similar intensity, indicating the formation of the two
products is linked. The rate of product formation by SXE is in
stark contrast to XE alone, which yielded almost no discernable
product under these conditions. Therefore, mini-SLX4 not only
influences XPF-ERCC1 catalysis at the first site but also rapidly
induces a second incision.Molecular Cell 54, 472–484, May 8, 2014 ª2014 The Authors 479
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Figure 6. SLX4 Increases the Efficiency of XPF-ERCC1 ICL Unhooking
(A) WT SXE or SXE harboring either XPF D678A or R690Smutations were incubated with the ICL substrate labeled at the 50 end. ICL cleavage products are clearly
seen with WT SXE, whereas SXE R690S (associated with human FA) shows very weak activity. The cleavage products are illustrated with a green arrow, red
bracket, and red arrow (as described in Figure 5). A noncrosslinked oligonucleotide contaminant is marked with an asterisk.
(B) Representative time course, comparing reaction of ICL substrate with either XE or SXE.
(C) Rates of substrate turnover for ICL or equivalent noncrosslinked control, calculated from data presented in (B).
(D) Graph representing the ICL product formation for XE (blue) and SXE (red) enzyme complexes. Filled symbols mark the first incision product (shown in B above
as a green arrow), open symbols depict 15 nt product (B, red arrow). The accumulation of the 15 nt product is dependent on the first product and marks the
‘‘unhooking’’ of the crosslink. Assays were performed with 5 nM enzyme complex and 1.5 pM labeled substrate, incubated for the time indicated, quenched,
and separated by 12% denaturing PAGE gel. Data in (C) and (D) are plotted from a minimum of three independent experiments; error bars represent SEM.
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We confirmed nuclease activity on the ICL substrate was
intrinsic to the SXE complex, by comparing WT SXE to that car-
rying XPF D688A. In addition, we tested SXE with XPF R690S
point mutation (Figures 3A and S2), which results in a substitu-
tion close to the enzyme’s catalytic site and greatly diminishes
nuclease activity (Figure 6A). R690S is equivalent to themutation
recently described in an FA patient (Bogliolo et al., 2013). This
mutation in XPF almost abolished the activity of SXE on our
crosslinked DNA substrate. These XPF mutants also had no ac-
tivity in the absence of SLX4 (XE data not shown). Therefore, only
theWT XPF protein in the SXE complex could efficiently catalyze
ICL unhooking.480 Molecular Cell 54, 472–484, May 8, 2014 ª2014 The AuthorsHaving established that mini-SLX4 stimulated ICL unhooking
by XPF-ERCC1, we wanted to quantify this effect in comparison
with a noncrosslinked control (YF). XE and SXE shared the same
cleavage sites on the YF and ICL substrate (Figure 5B). However,
when we compared incision rates on the ICL substrate, the half-
life for SXEwas 34 s, compared to >60min for XE (Figures 6A and
6B; Table S2). This is equivalent to a 110-fold increase in the cat-
alytic rate of XPF-ERCC1 on a crosslinked substrate (Figure 6C).
Reaction kinetics for the ICL were very similar to YF, indicating
the crosslinked adduct does not pose a significant obstacle to
SXE nuclease activity (Figure S4C). Furthermore, a time course
confirmed the temporality of product formation from the ICL sub-
strate (Figure 6D). The SXE reaction was initiated with the rapid
Molecular Cell
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subsequently converted to 15 nt product. For XE digestion, the
complete unhooking reaction was limited by primary product
formation (>>35 nt). Finally, we used our ‘‘incised ICL’’ to inves-
tigate the efficiency of the second incision by both nuclease
complexes (Figures S6C and S6D). The time course revealed
that XE was also markedly inefficient in making the second inci-
sion, compared to SXE (determined by 15 nt product formation).
Taken together, these biochemical data suggest a critical func-
tion of SLX4 in ICL repair is in accelerating XPF-ERCC1 unhook-
ing crosslinked DNA.
DISCUSSION
Thiswork provides insight into the physiological and biochemical
function of SLX4 in DNA repair. This important DNA repair protein
is not merely a passive scaffold but rather acts as a factor that
greatly stimulates the activity of the XPF-ERCC1 nuclease
toward certain substrates. These features are exemplified by
the ability of SLX4-XPF-ERCC1 complex to unhook an ICL at a
synthetic replication fork.
Our previous genetic characterization of Slx4-deficient mice
showed that homozygous animals exhibited a phenotype that
shared many features with human FA. Consistent with this is
the discovery that biallelic mutations in SLX4 result in classical
FA, making SLX4 the 15th FA complementation group (FANCP)
(Kim et al., 2011; Stoepker et al., 2011). Currently, the FANCP
group consists of very few families, with individuals displaying
a broad range of clinical features from varied developmental
defects to bone marrow failure. Only one FANCP patient has
developed malignant disease (a squamous cell carcinoma of
the tongue) (Kim et al., 2011). Our observation that Slx4f3/f3
mice surviving to adulthood develop epithelial cancers estab-
lishes this DNA repair gene as a tumor suppressor.
A key feature of FA-deficient cells, including Slx4 deficiency, is
hypersensitivity to DNA interstrand crosslinking agents. This is
due to an inability to repair a DNA crosslink. There is an emerging
body of evidence showing that the upstream FA proteins are
critical for orchestrating unhooking at the site of a crosslink (De
Silva et al., 2000; Knipscheer et al., 2009), whereas downstream
FA proteins are required for HR-mediated repair of the double-
strand breaks generated by the incision step. SLX4 binds three
nucleases, all of which are implicated in crosslink repair. Despite
this, it has not been resolved at which stage of crosslink repair
SLX4 and its associated nucleases act.
The work presented here shows that SLX4, in complex with
XPF-ERCC1, is a far more potent nuclease than XPF-ERCC1
alone. Moreover, SLX4 imparts structural preference on XPF-
ERCC1 toward DNA flaps and replication-like structures over
stem-loop or bubble substrates (those bearing greater similarity
to nucleotide excision repair substrates) without a free 30 over-
hang. This stimulation of activity does not appear to be due to
enhanced substrate binding, suggesting that its effect is more
likely due to altered catalysis on specific substrates. Our data
reveal that the individual proteins are present with 2:2:2 stoichi-
ometry in the SXE complex, implying that each SXE complex
contains two active sites of XPF. It is tempting to speculate
that this may influence enzyme efficiency and potentially pro-vides a mechanism by which enhanced catalysis is achieved.
Our studies show that a minimal SXE complex is capable of
dual incisions at either side of a DNA crosslink. The SXE complex
primarily appears to recognize the 30 arm of a fork and that
cutting occurs 1 and 4 nt from the ss/ds junction. It is well known
that XPF-ERCC1 is crucial for crosslink repair and that it can
biochemically unhook a crosslink, but it is unclear the efficiency
with which it achieves this (Fisher et al., 2008; Kuraoka et al.,
2000). Our comparison of SLX4-XPF-ERCC1 complex and
XPF-ERCC1 alone shows that SLX4 greatly stimulates this
nuclease activity, which can be integrated into a model of ICL
repair (Figure 7). Recently, it has been discovered that XPF-
ERCC1 is critical for ICL incision in a Xenopus system, depen-
dent upon monoubiquitylated FANCD2 (Klein Douwel et al.,
2014; Knipscheer et al., 2009). Furthermore, it was previously
shown that the leading strand template remains intact in this pro-
cess (Ra¨schle et al., 2008). While this may suggest a major differ-
ence between the activity we report andwhat is seen inXenopus,
a few points need to be taken into consideration. The Xenopus
model of ICL repair involves two converging replication forks. It
is therefore possible that the dual incisions we observe take their
cue from the replication fork coming from the opposite direction
toward the ICL. This would still leave an intact, adducted
parental strand as template for TLS. The in vitro Xenopus system
might also have additional factors that specifically restrict the
activity of SXE nuclease complex to favor a particular arm (for
example, preloading Rad51 onto ssDNA; Long et al., 2011).
Indeed, although dependent on monoubiquitylated FANCD2,
the mechanism by which SLX4-XPF-ERCC1 is recruited to site
of the crosslink is uncertain. The recruitment may occur through
the direct interaction of SLX4 andmonoubiquitylated FANCD2 or
indirectly, through an intermediary (Yamamoto et al., 2011).
Mini-SLX4 that interacts with only one nuclease XPF-ERCC1
does not fully rescue ICL sensitivity in SLX4-deficient cells, unlike
the full-length protein. Therefore, parts of SLX4 distal to our trun-
cation also contribute to ICL repair. The most likely candidates
are the two other nucleases (MUS81-EME1 or SLX1), because
cells deficient in them are sensitive to ICLs (Dendouga et al.,
2005; Kratz et al., 2010; MacKay et al., 2010; McPherson et al.,
2004). It is likely that either of these nucleases and/or just the
distal part of SLX4 might play a role in later stages of ICL repair,
such as inHR-mediated double-strand break repair. In summary,
the experiments presented in this paper elucidate a genetic and
biochemical function for murine SLX4, defining how this protein
functions in ICL repair when bound only to XPF-ERCC1.EXPERIMENTAL PROCEDURES
Please refer to the Supplemental Experimental Procedures for detailed meth-
odology on strains, clonogenic assays, fluorescence-activated cell sorting
analysis, cloning and mutagenesis (Table S4), protein expression and purifica-
tion, size-exclusion chromatography-multiangle static light-scattering, mass
spectrometry and nuclease substrates (including ICL synthesis), and compre-
hensive nuclease and binding assay conditions.
Mice
Btbd12f3/f3 generated in the C57BL/6NTac background were described previ-
ously (Crossan et al., 2011). All animal experiments undertaken in this study
were done so with the approval of the UK Home Office.Molecular Cell 54, 472–484, May 8, 2014 ª2014 The Authors 481
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Figure 7. Model for the Role of SXE in ICL Repair
(A) Monoubiquitylation of FANCD2 and FANCI (ID) by the FA core complex is
required for interstrand crosslink recognition.
(B) Ubiquitylated ID recruits SLX4 in complex with XPF-ERCC1 either directly
or via an unidentified intermediary protein(s). SXE preference for a 30 single-
stranded arm suggests the molecular recognition of the crosslink is triggered
by the convergence of both replication forks at the ICL.
(C) The presence of the leftward fork would trigger SXE cutting first 30 and
possibly then 50, unhooking the ICL.
(D) The intact (adducted) parental strand could then serve as a template for the
rightward fork extension by translesion synthesis.
(E) The adducted base can then be removed by a combination of nucleotide
excision repair and the newly synthesized chromatid used to repair the
resulting DSB. SLX4 involvement in this process may additionally require the
action of MUS81-EME1 and/or SLX1.
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482 Molecular Cell 54, 472–484, May 8, 2014 ª2014 The AuthorsFlow Cytometry
Flow cytometry was performed on bone marrow cells that were isolated from
the femora and tibiae of mutant mice as described previously (Garaycoechea
et al., 2012).
Immunoprecipitation and Western Blot Analysis
Immunoprecipitation and western blot analysis were performed using the
following antibodies: HA (Covance, MMS-101R), ERCC1 (Santa Cruz Biotech-
nology, FL297), XPF (Abcam, ab73720), anti-SLX4 (affinity purified rabbit
serum immunized with SLX4 1-758), swine anti-rabbit (DEKO, P0399), and
rabbit anti-mouse (DEKO, P0260).
Nuclease Assays
All reactions were carried out in nuclease buffer (NB): 10–50 mM Tris (pH 8.0),
50 mM NaCl, 2 mMMgCl2, 1 mM TCEP, 0%–5% glycerol, and 0.1 mg/ml BSA
(NEB) at 22C. Reactions were analyzed on 12% denaturing PAGE gel, and
data were fitted using GraphPad Prism. DNA is shown schematically in Fig-
ure S3, and sequences are listed in Table S3. Enzyme concentrations were
calculated assuming the complexes were monomeric (i.e., in comparison
the assays contain the same amount of XPF-ERCC1).
Fluorescent Anisotropy Binding Assay
Synthetic oligonucleotides stem loop (FAM) and Y-shaped DNA fork (Cy5)
were labeled with fluorescent probes on 50 terminus as shown in Figure 3D.
Enzyme complexes were prepared in 2-fold serial dilution, mixed 1:1 with
DNA substrate (50 nM), and analyzed using PHERAstar (BMG). Enzyme con-
centrations were calculated assuming complexes were monomeric.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, four tables, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.molcel.2014.03.014.
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